NYXH
Price:
$8
Market Cap:
$263.75M
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
2021-04-28
Stock Exchange
NASDAQ
Ticker
NYXH
According to Nyxoah S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -4.37. This represents a change of 0.86% compared to the average of -4.33 of the last 4 quarters.
The mean historical PE Ratio of Nyxoah S.A. over the last ten years is -29.24. The current -4.37 PE Ratio has changed 1.39% with respect to the historical average. Over the past ten years (40 quarters), NYXH's PE Ratio was at its highest in in the December 2022 quarter at -2.26. The PE Ratio was at its lowest in in the December 2019 quarter at -599.26.
Average
-29.24
Median
-29.02
Minimum
-63.20
Maximum
-2.72
Discovering the peaks and valleys of Nyxoah S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 31.21%
Maximum Annual PE Ratio = -2.72
Minimum Annual Increase = -77.88%
Minimum Annual PE Ratio = -63.20
Year | PE Ratio | Change |
---|---|---|
2023 | -2.72 | -29.49% |
2022 | -3.85 | -77.88% |
2021 | -17.42 | -39.96% |
2020 | -29.02 | -54.07% |
2019 | -63.20 | 31.21% |
2018 | -48.16 | 19.58% |
The current PE Ratio of Nyxoah S.A. (NYXH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8.00
5-year avg
-23.24
10-year avg
-29.24
Nyxoah S.A.’s PE Ratio is greater than Milestone Scientific Inc. (-13.41), less than Pro-Dex, Inc. (29.26), less than InfuSystem Holdings, Inc. (133.85), greater than KORU Medical Systems, Inc. (-13.48), less than Jin Medical International Ltd. (0), less than NEXGEL, Inc. (47.89), greater than Daxor Corporation (-6.18), less than LeMaitre Vascular, Inc. (13.43), less than Utah Medical Products, Inc. (58.73), less than Merit Medical Systems, Inc. (14.88), less than AtriCure, Inc. (51.10), greater than null (-43.25),
Company | PE Ratio | Market cap |
---|---|---|
-13.41 | $60.29M | |
29.26 | $152.37M | |
133.85 | $198.39M | |
-13.48 | $161.35M | |
0 | $165.94M | |
47.89 | $31.13M | |
-6.18 | $44.91M | |
13.43 | $2.43B | |
58.73 | $221.44M | |
14.88 | $6.14B | |
51.10 | $1.74B | |
-43.25 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nyxoah S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nyxoah S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Nyxoah S.A.'s PE Ratio?
How is the PE Ratio calculated for Nyxoah S.A. (NYXH)?
What is the highest PE Ratio for Nyxoah S.A. (NYXH)?
What is the 3-year average PE Ratio for Nyxoah S.A. (NYXH)?
What is the 5-year average PE Ratio for Nyxoah S.A. (NYXH)?
How does the current PE Ratio for Nyxoah S.A. (NYXH) compare to its historical average?